Helping eligible patients experiencing financial hardship
obtain medication

Forest Laboratories, LLC is pleased to offer the Aptalis Patient Assistance Program (PAP)*, which was created to help eligible patients receive financial assistance for the medications CANASA®, PYLERA®, RECTIV®, ULTRESA®, VIOKACE®, and ZENPEP®.

This program is designed for patients experiencing financial hardship who earn too much to qualify for government-funded programs, but don’t have third-party insurance coverage. The Aptalis PAP allows these patients greater access to the Forest Laboratories medication prescribed by their doctor.

*Forest Laboratories reserves the right at any time and without notice to modify eligibility criteria, modify or discontinue any or all aspects of the PAP or terminate any assistance provided by the PAP.

Covered medications include:

 
CANASA®, PYLERA®, RECTIV®, and VIOKACE® are registered trademarks of Actavis, Inc. or its affiliates.
ULTRESA® and ZENPEP® and their designs are registered trademarks of Actavis, Inc. or its affiliates.